Bright Minds Biosciences (DRUG) Current Leases (2022 - 2026)

Bright Minds Biosciences (DRUG) has 5 years of Current Leases data on file, last reported at $59889.7 in Q1 2026.

• Quarterly Current Leases rose 10.53% year-over-year to $59889.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59889.7 (up 10.53% YoY) and the FY2025 annual result came in at $61421.0, up 5.55% from the prior year.
• Current Leases eased to $59889.7 in Q1 2026, from $63215.5 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $63215.5 in Q4 2025 to a low of $10247.7 in Q2 2024.
• A 5-year average of $50130.1 and a median of $54433.5 in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases tumbled 82.21% — and 2025, when it jumped 450.65%.
• Tracing DRUG's Current Leases over 5 years: stood at $51505.8 in 2022, then decreased by 22.19% to $40078.5 in 2023, then advanced by 29.79% to $52017.2 in 2024, then advanced by 21.53% to $63215.5 in 2025, then decreased by 5.26% to $59889.7 in 2026.
• The last three Current Leases figures came in at $59889.7 (Q1 2026), $63215.5 (Q4 2025), and $61421.0 (Q3 2025), per Business Quant data.